Breaking News
Saturday , August 19 2017
Home / Tag Archives: Alembic Pharmaceuticals

Tag Archives: Alembic Pharmaceuticals

Alembic Pharmaceuticals receives USFDA approval for Amantadine Hydrochloride Capsules

Alembic Pharmaceuticals has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Amantadine Hydrochloride Capsules, USP, 100mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Symmetrel Capsules, 100mg, of Endo Pharmaceuticals Inc. Amantadine Hydrochloride Capsules have ... Read More »

Alembic Pharmaceuticals gets USFDA nod for Fenofibric Acid Delayed-Release Capsules

Alembic Pharmaceuticals has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Fenofibric Acid Delayed-Release Capsules, 45 mg and 135 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Trilipix Delayed-Release Capsules, 45 mg and 135 ... Read More »

Alembic Pharmaceuticals reports marginal rise in Q4 consolidated net profit

Alembic Pharmaceuticals has reported results for fourth quarter and year ended March 31, 2017. The company has reported a fall of 33.21% in its net profit at Rs 59.24 crore for the quarter ended March 31, 2017 as compared to Rs 88.70 crore for the same quarter in the previous ... Read More »